Loading…

Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis

The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and molecular hepatology 2018, 24(3), , pp.319-330
Main Authors: Gu, Dae Hoe, Kim, Moon Young, Seo, Yeon Seok, Kim, Sang Gyune, Lee, Han Ah, Kim, Tae Hyung, Jung, Young Kul, Kandemir, Altay, Kim, Ji Hoon, An, Hyunggin, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo, Um, Soon Ho
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate the optimal cutoff values of PMTH for detecting sarcopenia in cirrhotic patients. All cirrhotic patients who underwent abdominal computed tomography (CT) scan including L3 and umbilical levels for measuring SMI and transverse psoas muscle thickness, respectively, were included. Two definitions of sarcopenia were used: (1) sex-specific cutoffs of SMI (≤52.4 cm2 /m2 in men and ≤38.5 cm2 /m2 in women) for SMI-sarcopenia and (2) cutoff of PMTH (
ISSN:2287-2728
2287-285X
DOI:10.3350/cmh.2017.0077